Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis.

Ruijgrok EJ, Fens MH, Bakker-Woudenberg IA, van Etten EW, Vulto AG.

Antimicrob Agents Chemother. 2006 May;50(5):1852-4.

2.

[Curative antifungal treatment of invasive pulmonary aspergillosis].

Andrès E, Courouau F, Kurtz JE, Limacher JM, Quoix E.

Rev Pneumol Clin. 1995;51(4):228-31. Review. French.

PMID:
7501940
3.

Liposomal amphotericin-B as a therapeutic measure to control experimental aspergillosis in BALB/c mice.

Ahmad I, Sarkar AK, Bachhawat BK.

Indian J Biochem Biophys. 1990 Dec;27(6):370-4. Review. No abstract available.

PMID:
2102483
4.

Role of nebulized amphotericin B in the management of allergic bronchopulmonary aspergillosis in cystic fibrosis: Case report and review of literature.

Casciaro R, Naselli A, Cresta F, Ros M, Castagnola E, Minicucci L.

J Chemother. 2015 Oct;27(5):307-11. doi: 10.1179/1973947814Y.0000000194. Epub 2014 May 14. Review.

PMID:
24824366
5.

Role of inhaled amphotericin in allergic bronchopulmonary aspergillosis.

Sehgal IS, Agarwal R.

J Postgrad Med. 2014 Jan-Mar;60(1):41-5. doi: 10.4103/0022-3859.128806. Review.

6.

Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis.

Beyer J, Schwartz S, Barzen G, Risse G, Dullenkopf K, Weyer C, Siegert W.

Infection. 1994 Mar-Apr;22(2):143-8. Review.

PMID:
8070928
7.

Nebulized Liposomal Amphotericin B for Treatment of Pulmonary Infection Caused by Hormographiella aspergillata: Case Report and Literature Review.

Godet C, Cateau E, Rammaert B, Grosset M, Le Moal G, Béraud G, Martellosio JP, Iriart X, Cadranel J, Roblot F.

Mycopathologia. 2017 Aug;182(7-8):709-713. doi: 10.1007/s11046-017-0117-9. Epub 2017 Jan 31. Review.

PMID:
28144821
8.

Nebulised liposomal amphotericin B for Aspergillus lung diseases: case series and literature review.

Godet C, Goudet V, Laurent F, Le Moal G, Gounant V, Frat JP, Cateau E, Roblot F, Cadranel J.

Mycoses. 2015 Mar;58(3):173-80. doi: 10.1111/myc.12294. Review.

PMID:
25690951
9.

A review on the clinical use of inhaled amphotericin B.

Kuiper L, Ruijgrok EJ.

J Aerosol Med Pulm Drug Deliv. 2009 Sep;22(3):213-27. doi: 10.1089/jamp.2008.0715. Review.

PMID:
19466905
10.

Chronic necrotizing pulmonary aspergillosis treated by endobronchial amphotericin B.

Bennett MR, Weinbaum DL, Fiehler PC.

South Med J. 1990 Jul;83(7):829-32. Review.

PMID:
2196695
11.

Fungal pneumonia (Part 4): invasive pulmonary aspergillosis.

Herbert PA, Bayer AS.

Chest. 1981 Aug;80(2):220-5. Review. No abstract available.

PMID:
6788456
12.
13.

Liposomal aerosols in the management of pulmonary infections.

Gilbert BE.

J Aerosol Med. 1996 Spring;9(1):111-22. Review.

PMID:
10160201
14.

Clinical practice guidelines for the treatment of invasive Aspergillus infections in adults in the Middle East region: Expert panel recommendations.

Al-Abdely HM, Alothman AF, Salman JA, Al-Musawi T, Almaslamani M, Butt AA, Al Thaqafi AO, Raghubir N, Morsi WE, Yared NA.

J Infect Public Health. 2014 Feb;7(1):20-31. doi: 10.1016/j.jiph.2013.08.003. Epub 2013 Sep 9. Review.

15.

Successful combination of antifungal agents and surgical resection for pulmonary aspergillosis in a child with Hodgkin disease: review of the literature.

Doganis D, Baka M, Pourtsidis A, Bouhoutsou D, Varvoutsi M, Stamos G, Anastasiou N, Androulakakis E, Vasilatou-Kosmidis H.

Pediatr Hematol Oncol. 2007 Dec;24(8):631-8. Review.

PMID:
18092254
16.

Aerosol and other novel administrations for prevention and treatment of invasive aspergillosis.

Drew RH.

Med Mycol. 2009;47 Suppl 1:S355-61. doi: 10.1080/13693780802247710. Epub 2008 Jul 24. Review.

PMID:
18654913

Supplemental Content

Support Center